Appeal | Dapagliflozin for treating chronic heart failure with reduced ejection fraction | Guidance | NICE

An appeal has been lodged for this appraisal, however it was rejected. Below are the papers related to the appeal.

BHSF : Appeal letter (MSWord 37 KB)

Published:

24 February 2021
NICE : Scrutiny letter (MSWord 59 KB)

Published:

24 February 2021
BHSF : Response to scrutiny letter (MSWord 28 KB)

Published:

24 February 2021
NICE : Final scrutiny letter (MSWord 57 KB)

Published:

24 February 2021

This page was last updated: 24 February 2021